Affiliation
Department of Cardiology, St James' Hospital, St James' Street, Dublin 8,, Ireland. faisalshareef@yahoo.comIssue Date
2012-02-01T10:45:33ZMeSH
Coronary Stenosis/complications/*diagnosis*Diagnostic Imaging/methods
Humans
Predictive Value of Tests
Severity of Illness Index
Metadata
Show full item recordCitation
Catheter Cardiovasc Interv. 2010 Jan 1;75(1):135-44.Journal
Catheterization and cardiovascular interventions : official journal of the, Society for Cardiac Angiography & InterventionsDOI
10.1002/ccd.22164PubMed ID
19670307Abstract
Critical coronary stenoses have been shown to contribute to only a minority of acute coronary syndromes (ACS) and sudden cardiac death. Autopsy studies have identified a subgroup of high-risk patients with disrupted vulnerable plaque and modest stenosis. Consequently, a clinical need exists to develop methods to identify these plaques prospectively before disruption and clinical expression of disease. Recent advances in invasive and noninvasive imaging techniques have shown the potential to identify these high-risk plaques. The anatomical characteristics of the vulnerable plaque such as thin cap fibroatheroma and lipid pool can be identified with angioscopy, high frequency intravascular ultrasound, intravascular MRI, and optical coherence tomography. Efforts have also been made to recognize active inflammation in high-risk plaques using intravascular thermography. Plaque chemical composition by measuring electromagnetic radiation using spectroscopy is also an emerging technology to detect vulnerable plaques. Noninvasive imaging with MRI, CT, and PET also holds the potential to differentiate between low and high-risk plaques. However, at present none of these imaging modalities are able to detect vulnerable plaque neither has been shown to definitively predict outcome. Nevertheless in contrast, there has been a parallel development in the physiological assessment of advanced atherosclerotic coronary artery disease. Thus recent trials using fractional flow reserve in patients with modest non flow-limiting stenoses have shown that deferral of PCI with optimal medical therapy in these patients is superior to coronary intervention. Further trials are needed to provide more information regarding the natural history of high-risk but non flow-limiting plaque to establish patient-specific targeted therapy and to refine plaque stabilizing strategies in the future.Language
engISSN
1522-726X (Electronic)1522-1946 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1002/ccd.22164
Scopus Count
Collections
Related articles
- Intravascular modalities for detection of vulnerable plaque: current status.
- Authors: MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK
- Issue date: 2003 Aug 1
- [Vulnerable high-risk plaque (thin cap fibroatheroma): vulnerable patient/vulnerable blood].
- Authors: Sezer M
- Issue date: 2006 Apr
- Imaging of vulnerable coronary artery plaques.
- Authors: Hamdan A, Assali A, Fuchs S, Battler A, Kornowski R
- Issue date: 2007 Jul 1
- Vulnerable plaques, inflammation and newer imaging modalities.
- Authors: Bhatia V, Bhatia R, Dhindsa S, Virk A
- Issue date: 2003 Oct-Dec
- Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory.
- Authors: Valgimigli M, Agostoni P, Serruys PW
- Issue date: 2007 Apr